• Global drug delivery innovator Lexaria Bioscience is researching the ability of its patented DehydraTECH(TM) technology to improve the performance of a number of prescription drugs
• Lexaria is a world leader in the investigation of a DehydraTECH-processed cannabidiol (“CBD”) to potentially treat high blood pressure (hypertension), and study outcomes thus far have rendered positive results on effectiveness and patient tolerance
• The company is building a scorecard of data to support its planned FDA application for formal, registered clinical testing under the Investigational New Drug (“IND”) process
• Lexaria recently completed all data analyses of its HYPER-H21-3 study examining DehydraTECH-CBD’s ability to reduce pulmonary artery systolic pressure, and launched HYPER-H21-4 to gather a variety of data points related to DehydraTECH-CBD’s use over a more extensive period of time

High blood pressure has long been labeled “the silent killer” because of its propensity to lead to incapacitating or prematurely deadly strokes, heart attacks and other serious disease indications without necessarily foreshadowing pain or great discomfort. According to the World Health Organization (“WHO”), an estimated 1.28 billion adults aged 30-79 years worldwide have hypertension but only about 1 in 5 (21 percent) people with the condition have it under control with medical treatment (https://ibn.fm/uMZNh). During the past decade within the United States, about 49 percent of the population reported taking at least one prescription medication in the past 30 days in data sampling collected by the National Center for Health Statistics of the Centers for Disease Control and Prevention at selected times, while 24 percent of the individuals took three or more prescriptions and 13 percent took five or more (https://ibn.fm/apjBj). The data showed a marked increase over those persons sampled during the late 1980s to mid-1990s, particularly where multiple medications were concerned. And yet, a recent news report states that as few as 50 percent of patients take their medications exactly as prescribed (https://ibn.fm/ggwCv). Global drug delivery innovator Lexaria Bioscience (NASDAQ: LEXX) is devoting its research and product development to making drug substances more effective in their approach to treating medical conditions such as high blood pressure and, in the process, to overcoming many of the obstacles that may hinder their proper use by patients. The company’s patented DehydraTECH(TM) technology combines an active pharmaceutical ingredient (“API”) with a fatty acid oil and performing a patented dehydration synthesis process before ingestion The Company has demonstrated significant improvements of absorption into bloodstream and even into brain tissue, in as little as minutes after ingestion. One area of Lexaria’s research has focused on pursuing U.S. Food and Drug Administration (“FDA”) approval to begin formal, registered clinical testing of its DehydraTECH-processed cannabidiol (“CBD”) for the treatment of hypertension under the Investigational New Drug (“IND”) process. Lexaria recently announced the launch of its HYPER-H21-4 randomized, double blinded, placebo-controlled, cross-over study of DehydraTECH-CBD in relation to  hypertension, with the potential for enhancing Lexaria’s ability to treat cardiovascular and other disease states beyond hypertension that are related to increased arterial stiffness (https://ibn.fm/F1N9A). Lexaria has already completed other human studies. Last year, studies HYPER-H21-1 (https://ibn.fm/30edj) and HYPER-H21-2 (https://ibn.fm/RGDrr) provided evidence that DehydraTECH-CBD successfully reduced blood pressure in similarly hypertensive human volunteers, and Lexaria announced earlier this month that it had completed all data analyses of its HYPER-H21-3 study with positive safety and efficacy findings (https://ibn.fm/HS9sV). HYPER-H21-3 used a placebo-controlled and double-blinded design with 16 volunteers, safely simulating hypoxia conditions (reduced oxygen availability) to induce lung artery constriction, or pulmonary hypertension, to analyze the ability of DehydraTECH-CBD to reduce pulmonary artery systolic pressure. HYPER-H21-4 will include 60 people and will be the most comprehensive study Lexaria has conducted to date. Dosing in more than half the volunteers has already begun and all treatment visits are expected to be finished by early July. The volunteers are between the ages of 40 and 70 with documented or measured elevated blood pressure, mild hypertension or moderate (stage 2) hypertension. The participants will use an escalating dose of DehydraTECH-CBD every day for a 5-week duration, establishing data for DehydraTECH-CBD’s extended use over time and providing secondary data outcomes that may ultimately lead to additional applications for DehydraTECH-CBD, according to the company. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Delic is a leader in new medicines and treatments that offers education, research, high-quality products, and treatment options
• The company is on a mission to help heal the mental health pandemic, which has been triggered and worsened by the COVID-19 disease
• Delic operates the largest, most profitable chain of wellness clinics providing ketamine treatments in the United States
• With 13 clinics already in operation, Delic is eyeing expansion as it seeks to ensure 60-70% of Americans are within a 45-minute drive to its clinics

The latest data from the World Health Organization (“WHO”) shows that the COVID-19 pandemic has triggered a 25% increase in the number of cases of anxiety and depression globally. Caused by multiple exacerbating factors, including loneliness, suffering and death, fear of infection, financial worries, and grief, this increased prevalence has also coincided with the substantial disruption in mental health services, creating a gaping hole in the care of people leaving with these conditions (https://ibn.fm/Tzpcj). Delic Holdings (CSE: DELC) (OTCQB: DELCF), a leader in new medicines and treatments for a modern world, has stepped up its efforts as it looks to fill the gaps exposed by COVID-19’s battering of the health sector. “Our mission is to heal the planet. We want to help heal the mental health pandemic. I don’t think we could have come about at a better time. I think it’s necessary; I wish it weren’t so necessary, but it is, and so, when people need that help, we are here to provide it,” Delic Co-founder and CEO, Matt Stang, said in a January interview (https://ibn.fm/Ycnhe). To fulfill this mission, Delic offers education, through an impressive, assorted portfolio of media offerings, including a wellness event, digital lifestyle magazine, and podcast; research through Delic Labs, a federally-licensed cannabis and psilocybin research lab; and, most importantly, high-quality products and treatment options through wellness clinics operating under the Ketamine Wellness Centers brand. The company currently operates 13 wellness clinics across nine states, making it the owner of the largest, most profitable chain of wellness clinics in the United States. Looking ahead, Delic plans to maintain this lead with plans to open more clinics in multiple other locations. Ultimately, according to Stang, the company’s long-term vision for this expansion drive is to have 60-70% of the American population within a 45-minute drive to the clinics. The expansion is also strategic in other ways. During the interview, Stang estimated that some psychedelic substances such as MDMA (ecstasy) and psilocybin could receive “some form of approval” within the next one to two years, with other compounds slated for possible legal availability in the subsequent years. Accordingly, Delic is positioning its clinics to be the go-to wellness centers for patients once the nascent psychedelic drugs are finally available. “[Once the psychedelic drugs have received some form of FDA approval] Delic will be the place you can go – you’ll have a clinic in your backyard that you go to for psychedelic medicine treatment, just like any other type of pharmaceutical,” Stang explained. He further noted that the clinics will offer psychedelic medicine treatment on an in-person basis, where qualified professionals will sit with patients and walk them through the process, offering them the efficacy they seek and, as a result, helping them change their minds and lives. Through the Ketamine Wellness Centers, Delic is providing a scalable, trusted, and accessible network of psychedelic clinics with a repeatable, non-habit forming, and effective treatment process. The clinics, coupled with its research and development division, put the company at the center of the burgeoning psychedelics and mental health treatment industries. According to an Open Minds Market Intelligence Report, the spending on mental health treatment and services grew 52.1% between 2009 and 2019, reaching $225 billion (https://ibn.fm/dZpEf). Separately, the global psychedelic drugs market is expected to grow robustly at a CAGR of 14.5% between 2021 and 2026, from $3.21 billion to $6.33 billion (https://ibn.fm/uC6nJ). For more information, visit the company’s website at www.DelicCorp.com. NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF

Companies, entrepreneurs, startups, investors and growth companies are invited to attend the Tech Innovation Forum being held on May 10-11th, 2022 at the AV Irvine, 16500 Scientific, Irvine, CA. As we move towards the next industrial revolution, Southern California is leading the growth and emergence of companies in the tech, climate, and other featured industries. This forum offers tech companies and startups a wonderful and impactful opportunity to showcase their company’s talent and be discovered by potential investors. The forum is organized by Octane, a convening organization creating 20 years of results across Southern California’s technology and medical technology business ecosystem to connect people, capital, and resources. Octane’s mission is to create over 55,000 technology jobs by 2030 in Southern California. They host thousands of programs every year that have a global impact and reach. Tech Innovation Forum connects global leaders and investors via its hybrid model. The 2-day event will feature startups and tech companies who can leverage the valuable content offered by distinguished industry speakers and establish networking ties using the tremendous networking scope of this event. Notable investors will be making their presence known at the event to impart in-depth knowledge about the latest investor trends and discover small and mid-cap companies to build and grow relationships with. Companies can gain exposure and visibility through Octane’s network of investors and leading professionals in Southern California. Tech Innovation Forum focuses on companies that can pitch their business ideas and gain visibility on this phenomenal platform. Eminent speakers from Fintech, gaming, esports, semiconductors, and related backgrounds will be offering their views on the next wave of the industrial revolution in Southern California. The Tech Forum also offers a meeting app for interactive sessions. Budding entrepreneurs and investors can connect at this forum that features some of the most innovative companies in the tech space. Strategic advisors who can help early-stage companies flourish are invited to share their expertise as a sponsor or an attendee at the conference. Tech Innovation Forum offers a wide spectrum of opportunities for creating new jobs, encouraging better business and scaling startups to contribute towards strengthening the economical ecosystem of the region. Attendees will learn to deal with unprecedented challenges and showcase their company vision to leading investors. To learn more, please visit https://ibn.fm/IYHrM.

• GreenBox has secured an estimated $1 billion merchant accounts portfolio following the closing of an asset purchase agreement with Sky Financial & Intelligence
• The company reported approximately $2 billion in total processing volume for the full year 2021, meaning the acquired portfolio formed a significant part of GreenBox’s growth success story during the last financial year
• Already, GreenBox has recouped $14.5 million of the purchase in the form of residuals received by Sky in FY21 and expects to recover the remaining amount in less than six months
• Last year, the company acquired Northeast Merchant Services and ChargeSavvy LLC, adding an impressive roster of merchant accounts

For GreenBox POS (NASDAQ: GBOX), an emerging FinTech company building customized payment solutions supported by proprietary blockchain security and advanced token technology, acquisitions are a vital part of its growth strategy. During a March 31 earnings conference call that accompanied the release of the Fourth Quarter and Full Year 2021 results, company Chairman Ben Errez noted that acquisitions allow GreenBox “to purchase merchant portfolios, adding processing volume to our platform, and provide a way to obtain key licensing assets, both domestically and globally, that enable us to branch out and service more verticals and geographic locations” (https://ibn.fm/ID8Nd). In an April 7 announcement that embodies Errez’s statement, GreenBox celebrated the closing of an asset purchase agreement with Sky Financial & Intelligence (“Sky”) to acquire a portfolio of merchant accounts for $16 million and 500,000 restricted common shares. There will be no additional compensation for Sky as GreenBox capitalizes on the strength of its own sales team for new account acquisition (https://ibn.fm/FSZbN). According to GreenBox, one of Sky’s accounts, which has been integrated with GBOX’s technology and ecosystem for more than a year, formed a significant part of its growth story in 2021. Over that period, the portfolio increased to over $1 billion in processing volume, against a total processing volume of approximately $2 billion for the full year 2021 (“FY21”). In recognizing this portfolio’s potential and continued growth, particularly considering its contribution to the processing volume for Q1 2021, GreenBox opted to purchase and wholly own it. GreenBox further noted it had already recouped $14.5 million of the purchase price from residuals (profit contributions) received by Sky during FY21. As a result, the company observed, the cash outlay to purchase the merchant accounts portfolio in-house is roughly $1.5 million in cash. And based on the current rate generated by Sky’s portfolio residuals to GreenBox, the company expects to recover the balance in less than six months. “The acquisition of the substantial Sky portfolios is yet another stride forward for us and accomplishes two very important things,” commented Errez. “[First,] by bringing a large merchant account portfolio in-house, we eliminate the cost previously incurred from commissions and amplify our margin profile. Second, it allows GreenBox to own these customer relationships, securing a considerable portion of our processing volume base with the bonus of being able to offer additional revenue-generating solutions. Lastly, Sky’s processing volume played a vital role for us in meeting the fundamental hurdle requirements in our convertible note.” GreenBox’s recent purchase joins a number of similar acquisitions that now define its growth strategy. Last May, the company completed the acquisition of Northeast Merchant Services, a provider of comprehensive merchant credit card processing services, in a transaction that gave GBOX access to over 700 new retail merchant accounts (https://ibn.fm/lhkDX). Later, in July, the company closed the acquisition of ChargeSavvy LLC, bringing an impressive merchant client portfolio and POS system equipped with fraud detection capabilities (https://ibn.fm/mVjpp). For more information, visit the company’s website at www.GreenBoxPOS.com. NOTE TO INVESTORS: The latest news and updates relating to GBOX are available in the company’s newsroom at https://ibn.fm/GBOX

First Responders, Command Staff, or professionals that manage their public safety agency’s social media channels are invited to join their peers online on May 9-12, 2022, at the Premier Social Media Event for Public Safety Professionals and First Responders. The 2-day event will feature 15 curated sessions, from distinguished speakers about effective communication and transparency for managing incidents in public safety agencies. As social media becomes the premier platform for marketing and branding, the safety o consumer information and privacy is more critical than ever. Participants can join their peers at this virtual event to learn several tactics to identify and handle mistakes and learn how community feedback is important for managing social media events successfully. Featured sessions at the SMSS 2022:

• Efficient communication by law enforcement to ensure public safety in the case of an important event
• Basic branding guideline for rebranding on social media in an affordable manner
• Case study: Preparations and best practices before a large social media event and avoiding common mistakes to improve trust

Bringing in an industry experience of 10 years in social media, the events are carefully curated and discussed by seasoned speakers who offer the best tips on social media marketing for agencies and departments. Participants can meet and interact with a mix of speakers who will share important insights about how to tackle important social media issues for public safety firms and allow the agency to grow its online community in a safe and conducive environment. Some topics of discussion at the SMSS 2022 include social media and crisis communications, humanizing staff, improving agency reputation, and building relationships with your community. Attendees will also learn how to assess and audit their current social media initiatives. Individuals and agencies who are first Responders, Command Staff, or professionals managing their public safety agency’s social media channels, must attend this event for further learning and benefits. Other attendees lists:

• Public Information & Public Affairs
• Administrative Support
• Communications
• Digital Marketing & Digital Media
• Emergency Management
• Social Media & Content Management
• Community Service, Education & Outreach
• Community Affairs
• Public Relations
• Media Relations
• Customer Service
• Digital Engagement

Public safety agencies can leverage this phenomenal platform to gather important inputs to utilize in their business marketing. Aspiring companies can connect with social media influencers and potential investors/ giant firms looking for promising investments. This is a profitable avenue to boost learning, trading, and networking in the social media sector. For more information, please visit https://ibn.fm/HYXap.

• Countries facing high rates of fiat currency devaluation are considering the purchase of cryptocurrency as a more stable alternative
• The Lightning Network facilitates faster transactions for cryptocurrency and is also a low-fee alternative for sending and receiving payments
• LQwD has ten public nodes on the Network: in the U.S., India, Ireland, Germany, Indonesia, Italy, Singapore, Sweden, England, and France
• Highest capacity node is in the U.S., with 5.689273640 BTC (U.S. $224,452.01) and a channel count of 106 (established November 2021)
• The cryptocurrency market, although volatile, is estimated to reach U.S. $32,420 billion by 2027

Even before the war between Russia and Ukraine, currencies worldwide began experiencing devaluation. Devaluation is the official lowering of the value of a country’s currency, and as more states are facing this issue, many of them are seeking out cryptocurrency as an alternative. In terms of devaluation, the countries hit the hardest include:

• Brazil – 217.65% devaluation against the U.S. dollar 2011-2021
• South Africa – 102.74% devaluation against the U.S. dollar 2011-2021
• Mexico – 63.71% devaluation against U.S. dollar 2011-2021
• India – 58.58% devaluation against the U.S. dollar 2011-2021

These four countries are also estimated to be the four most likely candidates to purchase cryptocurrency within the next year, with percentages close to 50% (https://ibn.fm/HL5sM). According to Gemini’s 2022 Global State of Crypto report, 41% of those who purchased crypto in 2021 were first-time buyers, with ownership of crypto stemming from countries like Brazil (51%), Hong Kong (51%), and India (54%). Ultimately, the report expressed that inflation and devaluation of currencies are primary factors driving the growth of cryptocurrency (Bitcoin, Litecoin, Ethereum, etc.) worldwide. When implementing cryptocurrency as legal tender in any country, the facilitation of the transactions is crucial to the currency’s success. Traditional blockchain transactions are slow and often require higher fees per transaction, but the Lightning Network changes how these transactions are completed, offering faster transaction times and lower fees. The Lightning Network is a layer 2 payment protocol layered on top of a blockchain-based cryptocurrency and was created to solve the overall bitcoin scalability problem. Many companies have begun creating solutions that facilitate payments on the network, and one such company is LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF). LQwD released its platform-as-a-service offering (PaaS) https://lqwd.tech/ in November 2021, at which time they also launched their first Lightning Network node in the U.S., which now has a capacity of 5.689273640 BTC (U.S. $224,452.01) and a channel count of 106. Additionally, LQwD has released Lightning Network nodes in Ireland, Germany, Indonesia, Italy, Singapore, Sweden, England, India and France. The company is leveraging the Network with the goal of becoming a crucial player in the quest for bitcoin adoption worldwide. Despite recent volatility, the cryptocurrency market is still expanding. The market reached a value of U.S. $1,782 billion in 2021 and is expected to grow at a CAGR over the forecast period of 2022 to 2027, resulting in a value of U.S. $32,420 billion by 2027 (https://ibn.fm/6jyok). The driving factors for this growth include the increase in technology and digitization across industries, the legalization of cryptocurrency as legal tender in countries around the world, and the minimized risk of fraudulent, unwanted, or erroneous payments within the infrastructure. For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

• Sapientia launched its first white-label product- the Co-op Gold PURE Plant-Based Protein Twists- just six months after its acquisition by Eat Well Investment Group in June 2021
• This product has just been awarded the finalist status in the 29th annual Canadian Grand Prix New Product Awards 2022
• Sapientia’s Founder and CEO believes that this award is a testament to his team’s hard work and inventiveness, along with the market’s love for the product
• The award is also an indicator that Eat Well Group is on the right track, as it works towards disrupting the multi-billion-dollar snack food market
• Sapientia is led by Dr. Eugenio Bortone, a preeminent food scientist with a Ph.D. in Food Engineering, an MS in Nutrition, 25 issued patents, and over 25 years of food, snack foods, pet foods, formulation, product development, process scale-up, and commercialization experience. Dr. Bortone is well-known in the industry for being the lead developer in the multi-billion-dollar, award-winning Cheetos brand franchise of Frito Lay, a division of PepsiCo, including the invention of Twisted Cheetos, which drove over $2 billion in revenue

On June 30, 2021, Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) completed the acquisition of Sapientia Technology LLC, a food technology portfolio holding enterprise. At the time, Sapientia was known for its disruptive patents, which aimed at solving some of the major problems that large-scale snack-food companies have struggled with for years. Such problems included the utility of a snack, including texture, flavor, and offering a guilt-free, not fried, natural, and healthy alternative to most snack food products on the market today (https://ibn.fm/JA771). Fast forward to December 2021, the company had already launched its first white-label, better-for-you plant-based product, twisted curls, in what was a defining moment for Sapientia amid increasingly complex global supply chain challenges (https://ibn.fm/LkGNh). This specific product, the Co-op Gold PURE Plant-Based Protein Twists, would be sold in over 300 Federated Co-op stores across Western Canada and would be awarded finalist status in the 29th annual Canadian Grand Prix New Product Awards this year (https://ibn.fm/em8kc). While acknowledging the status, Sapientia’s Founder and Chief Executive Officer (“CEO”), Dr. Gino Bortone, noted that this award affirms his team’s hard work and inventiveness. He further acknowledged that it is a testament to the market’s love for the product. “Having our first commercialized product enter finalist status at the 29th annual Canadian Grand Prix New Product Awards is a testament to the hard work and inventiveness of our team and the market’s love for our ‘Protein Twists,’” noted Dr. Bortone. “We are incredibly proud of what we have accomplished in such a short period and can’t wait to expand our white-label product lines, and equally as important, launch Sapientia’s own branded products, which we look forward to sharing more details on in the near term,” he added. Eat Well Investment Group has maintained its thesis of investing in companies commercializing food-tech and R&D products, not within years of acquisition but within 12-18 months. This has seen it acquire Belle Pulses Ltd., one of the top pulse processors in Canada with over 40 years of operation and over $60 million in sales in 2020. It has also seen a 51% acquisition of Amara Organic Foods, with an option to acquire additional ownership up to 80%. With these acquisitions and investments, the company is positioning itself strategically within the plant-based foods market, which is projected to post a 7.7% growth by 2030 to be valued at $162 billion, up from $29.4 billion in 2020 (https://ibn.fm/qnosz). The launch of the Co-op Gold PURE Plant-Based Protein Twists was a move by Sapientia to disrupt the multi-billion-dollar snack food market by offering taste and nutrition “without compromise.”  Winning the Finalist status at the 29th annual Canadian Grand Prix New Product Award indicates that the company is on the right track and is taking over the industry, one product at a time. For more information, visit the company’s website at www.EatWellGroup.com. NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF

• FuelPositive is committed to developing clean fertilizer and energy solutions, such as their containerized green ammonia production system
• The company is emphasizing a decentralized model, which gives farmers and other end-users control over the ammonia supply chains, particularly in the wake of current disruptions brought by Russia’s invasion of Ukraine
• The system also eliminates CO2 emissions associated with the industrial production of grey ammonia
• FuelPositive established that the cost of production using its system was approximately 37.8% cheaper to the end-user than the delivered cost of anhydrous grey ammonia (in Manitoba, Canada)

As Russia continues to wage war against Ukraine, the conflict is leaving in its wake disruptions that have far-reaching effects worldwide, including the negative effects on agriculture and global food security. For instance, Russia and Ukraine are major global producers and exporters of fertilizers, grain, and other important nutrients and minerals, a status that presents a grim outlook for food prices and food security globally. The Food and Agriculture Organization of the United Nations (“FAO”) has, in fact, warned that the disruption arising from the war could influence an increase in international food prices by as much as 22% (https://ibn.fm/ITMYy). The agriculture sector is one of the sectors most affected, with most fertilizer prices having increased over 100% during the past several years. According to the statistics released in February by the United States Department of Agriculture ahead of the 2022 planting season, the price of anhydrous ammonia increased by 235% compared to 2021, urea rose by 149%, and liquid nitrogen shot upwards by 192% (https://ibn.fm/OzCzb). A Columbus Dispatch article notes that farmers are especially vulnerable to cost swings (https://ibn.fm/12g0N). While fertilizers account for more than 30% of their expenses, they cannot easily offset the price upfront – as they are usually paid post-harvest. This will leave them with no option other than to raise the price of their goods. Meanwhile, the growers have resorted to reducing the expenses by “spoon-feeding” their crops. They are applying only “the right kind of fertilizer at the right rate, at the right time, and in the right place.” But currently this practice only allows them to save between 5 to 10%, yet fertilizer prices are ballooning at an even higher rate. With inadequate fertilization, yields are reduced and food prices rise. These disruptions partly arise from the dependence on centralized supply chains that rely on large producers. For FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a company committed to clean energy solutions, the remedy is nigh, particularly for the agricultural sector. The company is emphasizing a decentralized model, which accords end-users control over supply and cost. FuelPositive’s flagship product is a containerized, modular, scalable green ammonia production system. Its demonstration units are expected to be rolled out later this year. The system generates green ammonia from sustainable electricity, air, and water and therefore, eliminates carbon dioxide (“CO2”) emissions linked to the industrial production of anhydrous grey ammonia, as well as the agricultural sector’s carbon footprint related to fertilizer production and distribution. The industrial production of anhydrous grey ammonia through the energy-intensive Haber Bosch process generates about 1.2% of global CO2 emissions or more than 450 million metric tons of CO2 annually (https://ibn.fm/3s4l1). When the CO2 production associated with the generation of hydrogen, a constituent of ammonia, is taken into account, the numbers increase even further. And with the agriculture sector using about 80% of the ammonia produced annually to satisfy its fertilizer needs, its carbon footprint becomes equally significant. In addition to reducing CO2 emissions, the FuelPositive system decentralizes ammonia production, freeing farmers from supply chain shocks, as is the case currently. In fact, a case study conducted last year revealed that the cost of green ammonia production using the company’s system was about CA$560 per metric ton compared to the then average landing cost of CA$900 per metric ton of grey ammonia – about 37.8% cheaper (https://ibn.fm/6iWWG). According to FuelPositive, the landing cost of grey anhydrous ammonia to farmers in Manitoba, Canada, had doubled from CA$600 to more than CA$1,200 per metric ton in just six months, further demonstrating the extent of the fluctuations. Current pricing per delivered metric ton of anhydrous ammonia in Manitoba is well over $2,000. The case study, the company observed, showed that its system offers independence from the widely fluctuating supply chain, a benefit that holds especially true given the current conflict-induced disruptions. “The war in Ukraine is a brutal reminder that our reality remains vulnerable to external shocks, so we should only build food systems that last and stand firm,” a Townhall opinion piece reads (https://ibn.fm/RedlB). And FuelPositive is helping build robust and decentralized food systems through its containerized, modular, scalable, and on-site green ammonia production system. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• Each autonomous security robot subscription comes with the Knightscope Security Operations Center (“KSOC”), which provides service opportunities, including recording/streaming, people detection, facial recognition, thermal anomaly detection, license plate recognition, and more
• Interested users can see the technology first-hand by visiting the website or by finding one of Knightscopes’ Robot Roadshow stops near them or requesting a stop in their town
• The Robot Roadshow is a virtually-led experience with real interactions for prospective clients with the ASR models and KSOC interface

The market for security robots was valued at $8.87 billion in 2020 and is expected to continue growing at a CAGR of approximately 14%, to reach $19.77 billion by 2026 (https://ibn.fm/8bvum). North America is anticipated to take up most of the market during the forecast period, and Knightscope (NASDAQ: KSCP) is uniquely positioned to capitalize on this growing sector. Knightscope is a leader in developing autonomous security capabilities, uniquely combining self-driving technology, robotics, artificial intelligence, and electric vehicles. Each autonomous security robot (“ASR”) that Knightscope produces is connected to the Knightscope Security Operations Center (“KSOC”). This is a fully functional, browser-based interface that is included with every subscription. KSOC provides access to real-time data around the clock, ensuring that the power of the ASR technology is always at the user’s fingertips. The KSOC technology integration in the ASRs is the first of its kind. Real-time monitoring includes:

• Recording and Streaming – offers users live 360-degree video, recorded video storage, and downloadable evidence files
• People Detection – provides detection for off-hours, alerts for restricted places, and is direct communication capable
• Facial Recognition – capacity to identify key person/VIPs, user-generated persons of interest, and offers workplace violence prevention
• Thermal – offers fire detection, heat blooms from recently driven vehicles, and people trying to conceal themselves in darkness
• Automatic License Plate Recognition – provides vehicle location assistance, permitted/prohibited plate monitoring, and parking monitoring

Knightscope’s fleet of ASRs delivers actionable intelligence, allowing security teams to detect and react more quickly in situations. The current fleet of operational ASRs includes K1, K3, and K5. Those interested in seeing the fleet in action can request the Knightscope Robot Roadshow stop in their city – or check a list of scheduled stops available on the company’s website to find the nearest location. The Robot Roadshow is virtually hosted by a Knightscope expert and demonstrates how the ASRs work and use the KSOC interface. For consumers considering one of Knightscope’s ASRs, this is an opportunity to interact with the interface and see the robots in action.  See the schedule at www.knightscope.com/roadshow In recent news, a K5 robot was deployed with a Fortune 500 company in Charlotte, NC. The large finance company implemented the ASR to help provide an even safer environment for customers and employees. The K5 robot is primarily used outdoors, with over 1 million hours of outdoor security logged across multiple winters and summers. The maximum speed of the K5 is 3 mph, and it weighs just under 400 pounds. The K5 is customizable and can be altered based on company branding. The weatherproof features of the K5 make it the perfect companion for outdoor security monitoring. For more information, visit the company’s website at www.Knightscope.com, and if you have a need for the subscription-based physical security service, you may request a private demonstration of the technology at www.Knightscope.com/demo. NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

• Delic Holdings Corp operates in North America to advance the use of psychedelics in treating difficult conditions related to major depression, PTSD and anxiety
• The company has a three-pronged approach to promoting access and affordability for treatment drugs: conducting research in its lab facility, advancing treatment through its clinical network, and educating the public through conferences and Web-based media
• The use of psychedelic drugs to treat these mental health concerns is gaining credibility some 50 years after hallucinogenic drugs reached their peak use and were generally declared illegal
• Delic recently received Health Canada authorization to obtain 60 grams of psilocybin mushrooms for its purposes and to conduct research using other psychedelics, such as MDMA (Ecstasy), LSD, DMT (Dimitri), mescaline and 2C-B.

On April 19, 1943, a Swiss chemical researcher experienced what has come to be known as “the world’s first intentional acid trip” as he experimented with the hallucinogenic effects of lysergic acid diethylamide (“LSD“) while riding his bicycle home from work. The day subsequently became celebrated as “Bicycle Day” by the drug’s users (https://ibn.fm/WN2av). Some 50 years after LSD and other psychedelic drugs reached their peak use in the United States, psychedelics are enjoying a new resurgence in popularity and possible legal authorization as medical researchers examine their potential to treat difficult mental disorders — particularly where psilocybin, the naturally hallucinogenic prodrug compound in “magic mushrooms,” is concerned (https://ibn.fm/mvupb). Psychedelic wellness company Delic Holdings (CSE: DELC) (OTCQB: DELCF) is a leader in new medicines and treatments for a modern world, making the health benefits more accessible and affordable to patients, and reframing the conversation around psychedelics. Coinciding with Bicycle Day, the company issued an update April 19 on Delic Co-founder and CEO Matt Stang’s appearances at the April 20 Sequire Cannabis and Psychedelic Conference and the April 22-24 Scottsdale Capital Event, where Stang was scheduled to meet with investors about the company’s strategic outlook for the remainder of the year and network with other industry insiders participating in the cannabis and psychedelic space (https://ibn.fm/EBwxG). The company sponsors outreach to industry companies and consumers through its annual Meet Delic psychedelic conference, which debuted last year as “the world’s largest psychedelic wellness event” with over 2,500 attendees and 16 hours of speakers and panel sessions in Las Vegas, as well as themed music and entertainment (https://ibn.fm/13BYm). This year’s event is scheduled for early November, with tickets already on sale (https://ibn.fm/by3IK). The scientific backbone of the company’s ecosystem is its Delic Labs research facility, which is federally authorized to work with psilocybin and cannabis to improve extraction, analytical testing and chemical processes while developing product lines and new intellectual property (“IP”). Delic Labs recently received a Health Canada 56 Research Exemption that allows its scientists to do research with a number of compounds outside of psychedelic mushrooms, including MDMA (Ecstasy), LSD, DMT (Dimitri), mescaline and 2C-B. Health Canada also authorized Delic Labs to acquire 60 grams of psilocybin mushrooms from Nectar Health Sciences Laboratory Division Inc., and the lab has applied for a Dealer’s License that would let it commercialize its psilocybin research and associated IP for medical and research purposes. The company also operates the largest ketamine clinic chain in the United States, Ketamine Wellness Centers (“KWC“), which has overseen 70,000 mental health treatments to date. Delic plans to open more state-of-the-art clinics by mid-2023 as part of its growing profile. “At Delic, we have built the most profitable model for scaling the best-in-class care directly to patients through the largest network of mental health clinics in the U.S.,” Delic Co-founder and CEO Matt Stang stated in January (https://ibn.fm/XTey8). “There are 51.5 million Americans who have experienced a mental health condition and the ongoing pandemic has only exacerbated the crisis. We are seeing a strong demand for alternatives to current treatments with lasting outcomes and less side effects. … Delic is well-positioned for growth and profitability in 2022 and beyond.” For more information, visit the company’s website at www.DelicCorp.com. NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF